Cetera Advisor Networks LLC Biogen Inc. Transaction History

Cetera Advisor Networks LLC

  • $0
  • Q1 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$212.02 - $267.71 $358,101 - $452,162
1,689 Added 26.72%
8,009 $1.73 Million
Q4 2023

Feb 13, 2024
BUY
$222.59 - $267.94 $51,195 - $61,626
230 Added 3.78%
6,320 $1.64 Million
Q3 2023

Nov 14, 2023
BUY
$253.3 - $285.89 $94,734 - $106,922
374 Added 6.54%
6,090 $1.57 Million
Q2 2023

Aug 09, 2023
BUY
$275.25 - $318.06 $120,559 - $139,310
438 Added 8.3%
5,716 $1.63 Million
Q1 2023

May 15, 2023
BUY
$256.56 - $292.34 $264,256 - $301,110
1,030 Added 24.25%
5,278 $1.47 Million
Q4 2022

Feb 14, 2023
BUY
$252.44 - $306.72 $520,783 - $632,763
2,063 Added 94.42%
4,248 $1.18 Million
Q3 2022

Nov 10, 2022
BUY
$194.69 - $268.46 $28,424 - $39,195
146 Added 7.16%
2,185 $583,000
Q2 2022

Aug 11, 2022
BUY
$187.54 - $223.02 $42,196 - $50,179
225 Added 12.4%
2,039 $415,000
Q1 2022

May 12, 2022
SELL
$193.77 - $244.14 $1,550 - $1,953
-8 Reduced 0.44%
1,814 $382,000
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $316,398 - $406,619
-1,413 Reduced 43.68%
1,822 $437,000
Q3 2021

Nov 16, 2021
BUY
$282.99 - $369.05 $35,656 - $46,500
126 Added 4.05%
3,235 $915,000
Q2 2021

Aug 13, 2021
BUY
$259.0 - $414.71 $342,657 - $548,661
1,323 Added 74.08%
3,109 $1.08 Million
Q1 2021

May 17, 2021
BUY
$242.95 - $284.63 $16,520 - $19,354
68 Added 3.96%
1,786 $500,000
Q4 2020

Feb 17, 2021
BUY
$236.26 - $355.63 $9,922 - $14,936
42 Added 2.51%
1,718 $421,000
Q3 2020

Nov 13, 2020
SELL
$264.77 - $305.71 $39,185 - $45,245
-148 Reduced 8.11%
1,676 $475,000
Q2 2020

Aug 13, 2020
SELL
$258.66 - $342.55 $40,092 - $53,095
-155 Reduced 7.83%
1,824 $488,000
Q1 2020

May 08, 2020
SELL
$268.85 - $341.04 $37,639 - $47,745
-140 Reduced 6.61%
1,979 $626,000
Q4 2019

Feb 10, 2020
BUY
$220.06 - $304.07 $58,535 - $80,882
266 Added 14.36%
2,119 $629,000
Q3 2019

Nov 06, 2019
SELL
$217.44 - $243.88 $110,676 - $124,134
-509 Reduced 21.55%
1,853 $430,000
Q2 2019

Aug 12, 2019
SELL
$219.29 - $241.72 $156,573 - $172,588
-714 Reduced 23.21%
2,362 $551,000
Q1 2019

May 06, 2019
BUY
$216.71 - $338.96 $39,441 - $61,690
182 Added 6.29%
3,076 $727,000
Q4 2018

Feb 15, 2019
BUY
$278.5 - $352.75 $195,228 - $247,277
701 Added 31.97%
2,894 $873,000
Q3 2018

Nov 14, 2018
BUY
$293.51 - $383.83 $33,166 - $43,372
113 Added 5.43%
2,193 $775,000
Q2 2018

Aug 14, 2018
SELL
$257.52 - $306.91 $303,616 - $361,846
-1,179 Reduced 36.18%
2,080 $605,000
Q1 2018

May 09, 2018
SELL
$260.13 - $367.91 $59,309 - $83,883
-228 Reduced 6.54%
3,259 $895,000
Q4 2017

Feb 08, 2018
BUY
$307.64 - $344.58 $262,109 - $293,582
852 Added 32.33%
3,487 $1.11 Million
Q3 2017

Nov 16, 2017
BUY
$281.15 - $329.69 $66,632 - $78,136
237 Added 9.88%
2,635 $826,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,398
2,398 $651,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email